Challenges to value-enhancing innovation in health care delivery
Subtitle: commonalities and contrasts with innovation in drugs and devices
By: Steven Garber ... [et al.].
Contributors: RAND Health; Kauffman-RAND Institute for Entrepreneurship Public Policy
Series: RAND Corporation occasional paper series; Occasional paper (Rand Corporation) -- OP-341.
Publisher: RAND Corporation
Published: 2011
Place of publication: Santa Monica, CA
Language: eng
Number of pages: 33
ISBN-13: 9780833059079
Subjects: Medical care; Medical innovations; Medical policy; Cost control; Medical economics
Description: "Limiting the growth of health care costs while improving population health is perhaps the most important and difficult challenge facing U.S. health policymakers. The role of innovation in advancing these social goals is controversial, with many seeing innovation as a major cause of cost growth and many others viewing innovation as crucial for improving the quality of care and health outcomes. The authors argue that mitigating the tension between improving health and controlling costs requires more-nuanced perspectives on innovation. More specifically, they argue that policymakers should carefully distinguish between innovative activities that are worth their social costs and activities that are not worth their social costs and try to encourage the former and discourage the latter. The paper considers innovation in drugs, devices, and methods of delivering health care, with particular attention to delivery"--
Notes: "Sponsored by RAND COMPARE and the Ewing Maron Kauffman Foundation."

"Rand Health and Kauffman-Rand Institute for Entrepreneurship Public Policy."

"OP-341-EMKF" --P. [4] of cover.

Includes bibliographical references (p. 29-33).

Also available via the Internet.